Arina Riabinska

Bergisch Gladbach, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Clinical-scale, modular manufacturing of tumor-reactive TILs using a closed and automated culture system.

Clinical-scale, modular manufacturing of tumor-reactive TILs using a closed and automated culture system.

Journal: Frontiers in immunology
Published: August 19, 2024

An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities.

An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities.

Journal: Blood cancer discovery
Published: January 15, 2021

Correction to: Pigment Epithelium-Derived Factor Improves Paracellular Blood-Brain Barrier Integrity in the Normal and Ischemic Mouse Brain.

Correction to: Pigment Epithelium-Derived Factor Improves Paracellular Blood-Brain Barrier Integrity in the Normal and Ischemic Mouse Brain.

Journal: Cellular and molecular neurobiology
Published: May 20, 2020

Pigment Epithelium-Derived Factor Improves Paracellular Blood-Brain Barrier Integrity in the Normal and Ischemic Mouse Brain.

Pigment Epithelium-Derived Factor Improves Paracellular Blood-Brain Barrier Integrity in the Normal and Ischemic Mouse Brain.

Journal: Cellular and molecular neurobiology
Published: August 22, 2019

ATM activity in T cells is critical for immune surveillance of lymphoma in vivo.

ATM activity in T cells is critical for immune surveillance of lymphoma in vivo.

Journal: Leukemia
Published: May 13, 2019

The Cdkn1aSUPER Mouse as a Tool to Study p53-Mediated Tumor Suppression.

The Cdkn1aSUPER Mouse as a Tool to Study p53-Mediated Tumor Suppression.

Journal: Cell reports
Published: October 27, 2017

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL.

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL.

Journal: Nature communications
Published: December 28, 2016

Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia.

Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia.

Journal: Nature communications
Published: August 22, 2016

Ercc1 Deficiency Promotes Tumorigenesis and Increases Cisplatin Sensitivity in a Tp53 Context-Specific Manner.

Ercc1 Deficiency Promotes Tumorigenesis and Increases Cisplatin Sensitivity in a Tp53 Context-Specific Manner.

Journal: Molecular cancer research : MCR
Published: March 18, 2016

Label-Free Protein-RNA Interactome Analysis Identifies Khsrp Signaling Downstream of the p38/Mk2 Kinase Complex as a Critical Modulator of Cell Cycle Progression.

Label-Free Protein-RNA Interactome Analysis Identifies Khsrp Signaling Downstream of the p38/Mk2 Kinase Complex as a Critical Modulator of Cell Cycle Progression.

Journal: PloS one
Published: December 08, 2014

Influence of pigment epithelium-derived factor on outcome after striatal cerebral ischemia in the mouse.

Influence of pigment epithelium-derived factor on outcome after striatal cerebral ischemia in the mouse.

Journal: PloS one
Published: July 10, 2014

Therapeutic targeting of a robust non-oncogene addiction to PRKDC in ATM-defective tumors.

Therapeutic targeting of a robust non-oncogene addiction to PRKDC in ATM-defective tumors.

Journal: Science translational medicine
Published: June 14, 2013
Showing 1-12 of 13

Last Updated: 09/26/2026